Want to see IN:ALBERTDAVD full AI Analyst Report?
ALBERTDAVD Stock Chart & Stats
₹788.40
-₹9.85(-0.75%)
At close: 4:00 PM EST
₹788.40
-₹9.85(-0.75%)
Day’s Range― - ―
52-Week Range₹581.30 - ₹959.35
Previous CloseN/A
Volume3.46K
Average Volume (3M)210.00
Market Cap
₹4.11B
Enterprise Value₹4.00B
Total Cash (Recent Filing)₹2.84B
Total Debt (Recent Filing)₹414.14M
Price to Earnings (P/E)―
Beta1.14
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.66%
Share Statistics
EPS (TTM)-26.43
Shares Outstanding5,707,162
10 Day Avg. Volume184
30 Day Avg. Volume210
Financial Highlights & Ratios
PEG Ratio2.06
Price to Book (P/B)0.86
Price to Sales (P/S)1.00
P/FCF Ratio-9.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthAlbert David's conservative financing — low leverage and substantially grown equity and assets — provides durable financial resilience. This structural strength supports credit flexibility, withstands short-term cash stress, and preserves capacity for capex or working-capital needs over the next several months.
Meaningful Gross Profit BaseDespite recent earnings weakness, the company retains significant gross profit dollars and showed solid profits through 2023–2024. A healthy gross margin base and manufacturing scale create a foundation for margin recovery if SG&A or working-capital pressures are addressed, supporting medium-term earnings potential.
Established Manufacturing & DistributionAlbert David’s integrated model—own manufacturing plus an existing sales/distribution network to wholesalers, hospitals and pharmacies—is a durable competitive asset. It sustains revenue flows, enables execution of contract manufacturing or scale benefits, and underpins recovery prospects over months.
Bears Say
Weak Cash GenerationThe shift from positive operating and free cash flow (2021–2024) to sustained negative cash flows in 2025–2026 is a durable operational concern. Persistent cash deficits can force external financing, constrain investment, and increase liquidity risk if working-capital dynamics aren't restored.
Profits Deteriorated To A LossTransitioning from peak net income in 2024 to a reported loss in 2026 indicates structural margin pressure or rising operating costs. Sustained negative operating profit undermines ROE and limits internal funding for growth, making operational fixes essential for medium-term recovery.
Revenue Volatility And Recent ContractionRevenue swings, including a contraction in 2025 and uneven trends thereafter, point to inconsistent demand or product mix pressures. This variability weakens predictability of cash flows and margins, complicating planning and raising execution risk across the next several quarters.
Albert David Ltd News
ALBERTDAVD FAQ
What was Albert David Ltd’s price range in the past 12 months?
Albert David Ltd lowest stock price was ₹581.30 and its highest was ₹959.35 in the past 12 months.
What is Albert David Ltd’s market cap?
Albert David Ltd’s market cap is ₹4.11B.
When is Albert David Ltd’s upcoming earnings report date?
Albert David Ltd’s upcoming earnings report date is Aug 06, 2026 which is in 32 days.
How were Albert David Ltd’s earnings last quarter?
Albert David Ltd released its earnings results on May 12, 2026. The company reported -₹37.56 earnings per share for the quarter, missing the consensus estimate of N/A by -₹37.56.
Is Albert David Ltd overvalued?
According to Wall Street analysts Albert David Ltd’s price is currently Overvalued.
Does Albert David Ltd pay dividends?
Albert David Ltd pays a Annually dividend of ₹5 which represents an annual dividend yield of 0.66%. See more information on Albert David Ltd dividends here
What is Albert David Ltd’s EPS estimate?
Albert David Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Albert David Ltd have?
Albert David Ltd has 5,707,162 shares outstanding.
What happened to Albert David Ltd’s price movement after its last earnings report?
Albert David Ltd reported an EPS of -₹37.56 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.987%.
Which hedge fund is a major shareholder of Albert David Ltd?
Currently, no hedge funds are holding shares in IN:ALBERTDAVD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Albert David Ltd
Albert David Limited is an Indian pharmaceutical company specializing in the production and distribution of a diverse array of medical products. Its offerings encompass pharmaceutical formulations, intravenous solutions, herbal medicines, bulk drug substances, and disposable medical devices like syringes and needles. The company's formulations address various therapeutic areas, including injectable medications (parenterals), oral and enteral drugs, topical applications, and vision care products. In addition to its operations within India, Albert David Limited actively exports its products to markets across Latin America, Southeast Asia, and different African nations. The company, established in 1938, is headquartered in Kolkata, India.
Technical Analysis
Alembic Pharmaceuticals Limited
―
Glenmark Pharmaceuticals Limited
―
IOL Chemicals & Pharmaceuticals Ltd.
―
IPCA Laboratories Limited
―
Unichem Laboratories Limited
―